Apixaban for the Prevention of Latent Biological Valve Thrombosis

Clinical trial NCT06184113 · UNKNOWN

Trial details

NCT number: NCT06184113
Sponsor: Clinical Hospital Centre Zagreb
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Aortic Valve Replacement Antithrombotic Therapy Bioprosthetic Valve Thrombosis Rapid Deployment Valves

Start date: 2023-12-01
Primary completion: 2025-12-01
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.